Ardsley Advisory Partners LP Mei Pharma, Inc. Transaction History

Ardsley Advisory Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.52 - $3.24 $80,798 - $103,884	-32,063 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$1.92 - $4.1 $34,439 - $73,541	-17,937 Reduced 35.87%	32,063 $85,000
Q2 2018 Aug 14, 2018	BUY	$1.89 - $4.95 $94,500 - $247,500	50,000 New	50,000 $197,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $372M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.